Anyone and of course bear,

from bear - "-The post hoc analysis from the pooled SUSTAIN and ASSURE clinical trials produced a 77% RRR of MACE in patients with DM for the entire group of patients. So there was no analysis conducted that separated the two statins vs placebo."

Is it possible that if the 5 pt MACE results are replicated in BoM, that eventually it could result in less CV death and better health in the long terms and,if so, might this have health, hence business merit?

Apologies because I think this may have been asked before.

GLTA

Toinv